US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

ホーム
投資
株式
イギリス
LSE
ArcticZymes Technologies ASA (0DRV) 銘柄情報

ArcticZymes Technologies ASA (0DRV)

6.60

0.00

(0.00%)

終了 7月6日 12:30AM

ArcticZymes Technologies ASA (0DRV) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

6.60

( - )

買値

6.60

売値

6.60

出来高

0.00

0.00 日の範囲 0.00

6.60 52 週間の範囲 6.60

時価総額

前日終値

6.60

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

kr 56,315

発行済株式数

51,071,390

配当利回り

PER

79.91

1 株当たり利益 (EPS)

0.25

歳入

128.37M

純利益

13.43M

ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing. The company offers shrimp alkaline phosphatase; cod UNG for use in viral and other molecular diagnostic ass... ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing. The company offers shrimp alkaline phosphatase; cod UNG for use in viral and other molecular diagnostic assays for the removal of contaminating dU-DNA; salt active nucleases for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other reagents; and double-strand specific DNases and derived kits for the removal of double stranded DNA. It also provides DNA/RNA polymerases for technology development for life science, molecular diagnostics, NGS, and synthetic biology; proteinase for microbiological diagnostics and liquid biopsies; and ligases for joining nucleic acids. The company serves the molecular tools market, and biomanufacturing markets. It operates in Norway, Germany, Lithuania, France, Italy, the United Kingdom, rest of Europe, the United States, and internationally. The company was formerly known as Biotec Pharmacon ASA and changed its name to ArcticZymes Technologies ASA in June 2020. ArcticZymes Technologies ASA was founded in 1990 and is headquartered in Tromsø, Norway. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.arcticzymes.com

本社

Tromsø, Norway

設立

1990

ArcticZymes Technologies ASA is listed in the sector of the ロンドン証券取引所 with ticker 0DRV. The last closing price for ArcticZymes Technologies... was kr6.60. Over the last year, ArcticZymes Technologies... shares have traded in a share price range of kr 6.60 to kr 6.60.

ArcticZymes Technologies... currently has 51,071,390 shares in issue. The market capitalisation of ArcticZymes Technologies... is kr337.07 million. ArcticZymes Technologies... has a price to earnings ratio (PE ratio) of 79.91.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	6.6	6.6	6.6	482	6.6	DE
52	0	0	6.6	6.6	6.6	810	6.6	DE
156	0	0	6.6	6.6	6.6	1175	6.6	DE
260	0	0	6.6	6.6	6.6	1956	6.6	DE

0DRV - Frequently Asked Questions (FAQ)

What is the current ArcticZymes Technologies ASA share price?

The current share price of ArcticZymes Technologies ASA is kr 6.60

How many ArcticZymes Technologies ASA shares are in issue?

ArcticZymes Technologies ASA has 51,071,390 shares in issue

What is the market cap of ArcticZymes Technologies ASA?

The market capitalisation of ArcticZymes Technologies ASA is NOK 337.07M

What is the 1 year trading range for ArcticZymes Technologies ASA share price?

ArcticZymes Technologies ASA has traded in the range of kr 6.60 to kr 6.60 during the past year

What is the PE ratio of ArcticZymes Technologies ASA?

The price to earnings ratio of ArcticZymes Technologies ASA is 79.91

What is the cash to sales ratio of ArcticZymes Technologies ASA?

The cash to sales ratio of ArcticZymes Technologies ASA is 8.08

What is the registered address of ArcticZymes Technologies ASA?

The registered address for ArcticZymes Technologies ASA is Sykehusveien 23, Tromsø, Troms, 9294

What is the ArcticZymes Technologies ASA website address?

The website address for ArcticZymes Technologies ASA is www.arcticzymes.com

gitreal

gitreal 6分前

You wouldn't have a bunch of shares you were given, or given cheaply, would you?

That would be pretty unethical to ask investors to buy at the ask, when you are the one dumping, wouldn't it?

RRP60

I still see smitty here occasionally. But i miss ILT. He is no longer showing up. I dont know what happened to his vault.

Doc logic

Doc logic 9分前

Legend431,

Like FeMike said, a little pop then back unless there is other news. Not too many really thought DCVax -L didn’t work. This just helps with reimbursement, competitive advantage and eventual submissions to others including FDA. The question folks want answered is how NWBO

radly

July 1st now September 30th. SMH

ORCA

I DO NOT SEE ANYTHING HAPPENING THIS YEAR.AND ON TOP OF IT,THE SELLING OF INSIDERS AT .01 BLOCKS ANY MINI RUN THAT THIS THING COULD HAVE. IN THE NEAR FUTURE.POSSIBLY GOING LOWER THIS WEEK.MAYBE .008.BUYING AT .008 AND SELL AT .0098 TO KEEP INSIDERS FROM SELLING.

G_rokk

G_rokk 11分前

It’s about the tech to reach a tumor and kill it
Without the side effects of chemo or radiation
Or surgery To help people and save lives
I pray RDGL gets a chance to prove its worth and bury idiots
that root for its failure

ScottishTexan

ScottishTexan 13分前

And there’s no dd worth posting on the incoming company and leadership team. Youre just mad you’ve been fleeced again. You should be used to it by now.

ScottishTexan

ScottishTexan 15分前

The dilution is coming . How do you think they will make payroll ?

ORCA

$BCDS WILL BE TREMENDOUS IN AUGUST.UNTIL THEN WE LOAD EVERY DOWN DAY.JELLY BEAN SELLERS KEEP THEM COMING.EVERYTHING FALLS ON MY LAP ALMOST EVERY DAY.LOL.

tat4tat

tat4tat 17分前

Yeah, like getting new contracts with all of those South American companies.

rogers711

rogers711 22分前

Says the one that has held a penny stock for years and made 0 👍😂 congrats! Imagine what you could have done with the money tied up here doing nothing… many permabulls here have tied up massive liquidity in a micro penny stock and think they are great investors…

stockrafter

stockrafter 23分前

It is obvious from all the patent filings for drugs, and fancy new injectors they are setting Halozyme to produce a number of internal Drug-concentration-enhanze/AI combos......Do doubt about it.....could easily make a list of few......On the way to $100 and beyond. AR

CatfishHunter

CatfishHunter 25分前

I doubt you will, but if so, best of luck flipping $50 for a 25%-45% gain.

Eths

SNTX
https://x.com/ethsbythelake/status/2073898723017470310?s=46&t=6Y7w8L7iBETCgMYpIXWuzg

3331

Math concludes BIEL will be the GOAT!
BIEL hitting PPS .10 puts it in the conversation for the greatest stock ever - more than 100,000% appreciation from their all-time low.

Two companies currently compete for the absolute top spot in modern history: Apple and former penny sto

Frank69OH

Frank69OH 30分前

Hey_Its_That_Guy

Hey_Its_That_Guy 31分前

I don't see those numbers on my Schwab. But stuff like that does happen. Hopefully we'll have a good week

Legend431

Legend431 31分前

Doc - I’m not paid here despite all the posts. Nothing is going to happen. Hope you had a great 4th

santafe2

santafe2 32分前

Quiet Sunday night so I'm working through a few ideas. Comments pro or con always welcome. This is a complex, short term, economic period.

We have the birth of the AI age which will alter economies as much or more than any previous technical revolution. That's the long term change. I

Telefon

Telefon 38分前

What would be involved in removing the Rat as CEO? Would it need to be initiated by the board of directors? Could shareholders hold a meeting and demand his removal?

rogers711

rogers711 38分前

Planning to buy this week after panic selling just like last time and buy in the .029-.036 range for a quick bounce back to .05 where it will sit for another year. All in my opinion…

S-BEES-BUMBLEBEE

S-BEES-BUMBLEBEE 39分前

Great! A massive jump in the share price is very possible here. $GDC $BTC

monentum2play

monentum2play 39分前

Everyone knows what a scammer he is, Nobody listens to him and not worth mentioning his name

ArcticZymes Technologies...

Rubicon Technologies (EM)

iShares S&P Consumer Dis...

Legacy Iron Ore

1.83% 26jul2030

Cheesecake Factory Dl 01

Nam Tai Property (PK)

Anson Resources

Adavale Resources (PK)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。